“The goal is to achieve immune tolerance after transplantation — when patients can safely discontinue immunosuppressive medications after life-saving transplant surgery. We believe transplantation “without drugs” has the potential to dramatically improve patients’ quality of life, and to extend patient survival and the longevity of the donated organ.

Following decades of pioneering research by the late Dr. Sam Strober at Stanford School of Medicine, our team successfully translated this work from the laboratory to patient care. For perfectly matched kidney transplant recipients, approximately 80% of patients have been able to discontinue immunosuppression — some for as long as 17 years. The success of this work has led to adoption of our protocol at transplant centers across the world.

We are now focused on expanding these advances to less well-matched transplant recipients and to patients who received their transplants years ago. Early results are highly encouraging and represent an important step toward transforming the future of transplantation.”